Kukje Pharma Co., Ltd. (002720.KS)
KSE · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩3,450 (+0.29%) as of
Key statistics
- Market cap
- 73.00B
- Dividend yield
- 0.87%
- 52-week range
- 2,810.00 – 5,470.00
- Beta
- 0.22
- Revenue (TTM)
- 181.27B
- Profit margin
- 2.76%
- Volume
- 471.24k
About Kukje Pharma Co., Ltd.
Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other antibiotics, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAIDS and other analgesics, gastrointestinal and cardiovascular agents, antidiabetics, genitourinary and respiratory agents, other ETC products, and other products. Kukje Pharma Co., Ltd. was founded in 1959 and is headquartered in Seongnam-si, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Seongnam-si, South Korea
- Employees
- 266
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.